<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="45806bf7-893a-4dd6-b9ab-c4dc6ce53946"><labelDrug name="INNOPRANXL"><Normalization/></labelDrug><generic name="propranolol hydrochloride"/><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.1" text="Drug Label for drug brand INNOPRANXL, containing propranolol hydrochloride." type="negative"><entity charOffset="0:19" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.1.e.0" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand INNOPRANXL," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="49:74" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.1.e.1" text="propranolol hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0282321" phraseText="propranolol hydrochloride." preferredWord="Propranolol Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.1.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.1.e.1"/></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.3" text="INNOPRAN XL (propranolol hydrochloride) is a nonselective, beta-adrenergic receptor-blocking agent for oral administration, available as an extended release product. " type="negative"><entity charOffset="13:38" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.3.e.0" text="propranolol hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0282321" phraseText="(propranolol hydrochloride" preferredWord="Propranolol Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="45:98" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.3.e.1" text="nonselective beta-adrenergic blocking agent" type="Biomedical_Entity"><Normalization><mmtx cui="C0304515" phraseText="a nonselective, beta-adrenergic receptor-blocking agent for oral administration," preferredWord="Non-selective beta-blocking agent" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="0:11" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.3.e.2" text="innopran xl" type="Biomedical_Entity"><Normalization><mmtx cui="C1311856" phraseText="INNOPRAN XL" preferredWord="Innopran XL" semType="phsu, orch"/><RxNorm RxCui="856468"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.3.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.3.e.1"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.3.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.3.e.0"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.3.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.3.e.1"/></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.6" text="These membranes are designed to retard release of propranolol hydrochloride for several hours after ingestion followed by the sustained release of propranolol." type="negative"><entity charOffset="50:75" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.6.e.0" text="propranolol hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0282321" phraseText="release of propranolol hydrochloride" preferredWord="Propranolol Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="147:158" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.6.e.1" text="propranolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033497" phraseText="followed by the sustained release of propranolol." preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.6.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.6.e.1"/></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7" text="The active ingredient in INNOPRAN XL is a synthetic beta-adrenergic receptor-blocking agent chemically described as 1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol hydrochloride. " type="negative"><entity charOffset="164:177" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.0" text="hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C1512523" phraseText="2-propanol hydrochloride." preferredWord="hydrochloride" semType="inch, phsu"/><RxNorm RxCui="1306114"/></Normalization></entity><entity charOffset="25:36" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.1" text="innopran xl" type="Biomedical_Entity"><Normalization><mmtx cui="C1311856" phraseText="The active ingredient in INNOPRAN XL" preferredWord="Innopran XL" semType="phsu, orch"/><RxNorm RxCui="856468"/></Normalization></entity><entity charOffset="52:91" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.2" text="beta-adrenergic blocking agent" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="a synthetic beta-adrenergic receptor-blocking agent chemically" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><entity charOffset="52:91" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.3" text="beta-adrenergic receptor agent" type="Biomedical_Entity"><Normalization><mmtx cui="C0178503" phraseText="a synthetic beta-adrenergic receptor-blocking agent chemically" preferredWord="beta adrenergic agent" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><entity charOffset="153:163" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.4" text="2-propanol" type="Biomedical_Entity"><Normalization><mmtx cui="C0022237" phraseText="2-propanol hydrochloride." preferredWord="Isopropyl Alcohol" semType="phsu, orch"/><RxNorm RxCui="797541"/></Normalization></entity><entity charOffset="4:21" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.5" text="active ingredient" type="Biomedical_Entity"><Normalization><mmtx cui="C1372955" phraseText="The active ingredient in INNOPRAN XL" preferredWord="Active ingredient" semType="phsu"/><RxNorm RxCui="215010"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.0"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.0"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.3" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.0"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.4" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.0"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.5" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.0"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.2"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.3"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.4"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.5" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.1"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.3" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.2"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.4"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.5" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.2"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.3" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.4"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.5" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.3"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.5" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.7.e.4"/></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11" text="Each capsule for oral administration contains sugar spheres, ethylcellulose, povidone, hypromellose phthalate, diethyl phthalate, hypromellose, polyethylene glycol, gelatin, titanium dioxide, and black iron oxide. " type="negative"><entity charOffset="87:99" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.0" text="hypromellose" type="Biomedical_Entity"><Normalization><mmtx cui="C0063242" phraseText="hypromellose phthalate," preferredWord="hypromellose" semType="phsu, carb"/><RxNorm RxCui="27334"/></Normalization></entity><entity charOffset="77:85" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.1" text="povidone" type="Biomedical_Entity"><Normalization><mmtx cui="C0032856" phraseText="povidone," preferredWord="Povidone" semType="phsu, bodm, orch"/><RxNorm RxCui="8610"/></Normalization></entity><entity charOffset="165:172" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.2" text="gelatin" type="Biomedical_Entity"><Normalization><mmtx cui="C0017237" phraseText="gelatin," preferredWord="Gelatins" semType="phsu, aapp, bodm"/><RxNorm RxCui="4716"/></Normalization></entity><entity charOffset="196:212" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.3" text="black iron oxide" type="Biomedical_Entity"><Normalization><mmtx cui="C3256111" phraseText="black iron oxide." preferredWord="Iron Oxide Black" semType="inch, phsu"/><RxNorm RxCui="236154"/></Normalization></entity><entity charOffset="130:142" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.4" text="hypromellose" type="Biomedical_Entity"><Normalization><mmtx cui="C0063242" phraseText="hypromellose," preferredWord="hypromellose" semType="phsu, carb"/><RxNorm RxCui="27334"/></Normalization></entity><entity charOffset="61:75" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.5" text="ethylcellulose" type="Biomedical_Entity"><Normalization><mmtx cui="C0059756" phraseText="ethylcellulose," preferredWord="ethyl cellulose" semType="phsu, orch"/><RxNorm RxCui="1310565"/></Normalization></entity><entity charOffset="144:163" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.6" text="polyethylene glycol" type="Biomedical_Entity"><Normalization><mmtx cui="C0032483" phraseText="polyethylene glycol," preferredWord="Polyethylene Glycols" semType="phsu, bodm, orch"/><RxNorm RxCui="54961"/></Normalization></entity><entity charOffset="174:190" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.7" text="titanium dioxide" type="Biomedical_Entity"><Normalization><mmtx cui="C0076733" phraseText="titanium dioxide," preferredWord="titanium dioxide" semType="inch, phsu"/><RxNorm RxCui="1305547"/></Normalization></entity><entity charOffset="46:59" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.8" text="sugar spheres" type="Biomedical_Entity"><Normalization><mmtx cui="C3255881" phraseText="sugar spheres," preferredWord="SUGAR SPHERES" semType="phsu, carb"/><RxNorm RxCui="71470"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.0"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.2"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.3"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.5" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.0"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.6"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.7"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.8" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.0"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.2"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.3"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.4"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.5" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.1"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.6"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.7"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.8" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.1"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.3"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.4" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.2"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.5" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.2"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.6" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.2"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.7"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.8" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.2"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.4" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.3"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.5" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.3"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.6" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.3"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.7" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.3"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.8" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.3"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.5" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.4"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.4" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.6"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.4" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.7"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.8" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.4"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.5" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.6"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.5" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.7"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.8" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.5"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.6" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.7"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.8" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.6"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.8" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.11.e.7"/></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.12" text="In addition, INNOPRAN XL 120 mg capsules contain yellow iron oxide." type="negative"><entity charOffset="49:66" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.12.e.0" text="yellow iron oxide" type="Biomedical_Entity"><Normalization><mmtx cui="C0772002" phraseText="yellow iron oxide." preferredWord="ferric oxide yellow" semType="inch, phsu, irda"/><RxNorm RxCui="259439"/></Normalization></entity><entity charOffset="13:24" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.12.e.1" text="innopran xl" type="Biomedical_Entity"><Normalization><mmtx cui="C1311856" phraseText="INNOPRAN XL 120 mg capsules" preferredWord="Innopran XL" semType="phsu, orch"/><RxNorm RxCui="856468"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.12.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.12.e.0"/></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.15" text="Propranolol is contraindicated in 1) cardiogenic shock, 2) sinus bradycardia, sick sinus syndrome, and greater than first-degree block unless a permanent pacemaker is in place, 3) bronchial asthma, and 4) in patients with known hypersensitivity to propranolol hydrochloride." type="negative"><entity charOffset="248:273" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.15.e.0" text="propranolol hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0282321" phraseText="to propranolol hydrochloride." preferredWord="Propranolol Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="0:11" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.15.e.1" text="propranolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033497" phraseText="Propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.15.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.15.e.0"/></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.18" text="Although beta-blockers should be avoided in overt congestive heart failure, some have been shown to be highly beneficial when used with close follow-up in patients with a history of failure who are well compensated and are receiving additional therapies, including diuretics as needed. " type="negative"><entity charOffset="265:274" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.18.e.0" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="136:151" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.18.e.1" text="close up" type="Biomedical_Entity"><Normalization><mmtx cui="C2946173" phraseText="used with close follow-up" preferredWord="Close Up" semType="phsu"/><RxNorm RxCui="221958"/></Normalization></entity><entity charOffset="9:22" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.18.e.2" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.18.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.18.e.0"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.18.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.18.e.0"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.18.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.18.e.1"/></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.19" text="Beta-adrenergic blocking agents do not abolish the inotropic action of digitalis on heart muscle." type="negative"><entity charOffset="71:80" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.19.e.0" text="digitalis" type="Biomedical_Entity"><Normalization><mmtx cui="C0304520" phraseText="the inotropic action of digitalis" preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="0:31" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.19.e.1" text="beta-adrenergic blocking agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="Beta-adrenergic blocking agents" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="9162"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.19.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.19.e.0"/></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.27" text="Propranolol should be administered with caution in this setting since it may block bronchodilation produced by endogenous and exogenous catecholamine stimulation of beta-receptors." type="negative"><entity charOffset="136:149" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.27.e.0" text="catecholamine" type="Biomedical_Entity"><Normalization><mmtx cui="C0007412" phraseText="exogenous catecholamine stimulation of beta-receptors." preferredWord="Catecholamines" semType="phsu, nsba"/><RxNorm RxCui="2146"/></Normalization></entity><entity charOffset="0:11" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.27.e.1" text="propranolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033497" phraseText="Propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.27.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.27.e.0"/></sentence><sentence biomedicalEntities="4" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29" lineNumber="23" text="Propranolol is a competitive inhibitor of beta-receptor agonists, and its effects can be reversed by administration of such agents, e.g., dobutamine or isoproterenol. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="119:130" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.1" text="such agents" type="Expression"/><antecedentEntity charOffset="42-64" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.0" text="beta-receptor agonists" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="70:73" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.10" text="its" type="Expression"/><antecedentEntity charOffset="0-11" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.7" text="Propranolol" type="Drug"/></anaphoraRelation><entity charOffset="42:64" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.0" text="beta-receptor agonists" type="Drug_Class"><Normalization><mmtx cui="C0243192" phraseText="a competitive inhibitor of beta-receptor agonists," preferredWord="agonists" semType="phsu"/><mmtx cui="C2987634" phraseText="a competitive inhibitor of beta-receptor agonists," preferredWord="Agonist" semType="phsu"/><RxNorm RxCui="38483"/></Normalization></entity><entity charOffset="138:148" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.3" text="dobutamine" type="Drug"><Normalization><mmtx cui="C0012963" phraseText="dobutamine" preferredWord="Dobutamine" semType="phsu, orch"/><RxNorm RxCui="203121"/></Normalization></entity><entity charOffset="152:165" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.5" text="isoproterenol" type="Drug"><Normalization><mmtx cui="C0022245" phraseText="isoproterenol." preferredWord="Isoproterenol" semType="phsu, orch"/><RxNorm RxCui="82030"/></Normalization></entity><entity charOffset="0:11" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.7" text="Propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="Propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="17:38" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.8" text="competitive inhibitor" type="Specific_Interaction"/><entity charOffset="74:97" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.12" text="effects can be reversed" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.3" drugClass="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.1"/><drugClassMembership drug="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.5" drugClass="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.1"/><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.7"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.ddi.2"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.12"><relations><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.10"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.7" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.0" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.8" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.10" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.1" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.12" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.30" lineNumber="23" text="However, such patients may be subject to protracted severe hypotension." type="irregular"><entity charOffset="52:70" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.30.e.0" text="severe hypotension" type="Specific_Interaction"/><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.30.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.30.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29" text="Propranolol is a competitive inhibitor of beta-receptor agonists, and its effects can be reversed by administration of such agents, e.g., dobutamine or isoproterenol. "><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.0"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29" text="Propranolol is a competitive inhibitor of beta-receptor agonists, and its effects can be reversed by administration of such agents, e.g., dobutamine or isoproterenol. "><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.29.e.7"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.31" text="Beta-adrenergic blockade may prevent the appearance of certain premonitory signs and symptoms (pulse rate and blood pressure changes) of acute hypoglycemia, especially in labile insulin-dependent diabetics. " type="negative"><entity charOffset="178:185" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.31.e.0" text="insulin" type="Biomedical_Entity"><Normalization><mmtx cui="C1533581" phraseText="especially in labile insulin-dependent diabetics." preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="16:24" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.31.e.1" text="blockade" type="Biomedical_Entity"><Normalization><mmtx cui="C3540676" phraseText="Beta-adrenergic blockade" preferredWord="Blockade" semType="phsu"/><RxNorm RxCui="1423936"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.31.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.31.e.0"/></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.37" text="Propranolol may change thyroid-function tests, increasing T4 and reversing T3, and decreasing T3." type="negative"><entity charOffset="0:11" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.37.e.0" text="propranolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033497" phraseText="Propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="65:77" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.37.e.1" text="reversing t3" type="Biomedical_Entity"><Normalization><mmtx cui="C0041017" phraseText="reversing T3," preferredWord="Reverse Triiodothyronine" semType="phsu, aapp, horm"/><RxNorm RxCui="10817"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.37.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.37.e.1"/></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.48" text="While taking beta-blockers, patients with a history of severe anaphylactic reaction to a variety of allergens may be more reactive to repeated challenge, either accidental, diagnostic, or therapeutic. " type="negative"><entity charOffset="100:109" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.48.e.0" text="allergens" type="Biomedical_Entity"><Normalization><mmtx cui="C3274161" phraseText="of allergens" preferredWord="Allergen (brand of diphenylpyraline)" semType="phsu, orch"/><RxNorm RxCui="1297244"/></Normalization></entity><entity charOffset="13:26" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.48.e.1" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="taking beta-blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.48.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.48.e.0"/></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.50" text="In patients with hypertension, use of propranolol has been associated with elevated levels of serum potassium, and serum transaminases and alkaline phosphatase. " type="negative"><entity charOffset="100:109" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.50.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="associated with elevated levels of serum potassium," preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="38:49" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.50.e.1" text="propranolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033497" phraseText="use of propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.50.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.50.e.0"/></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.51" text="In severe heart failure, the use of propranolol has been associated with increases in blood urea nitrogen." type="negative"><entity charOffset="36:47" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.51.e.0" text="propranolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033497" phraseText="the use of propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="92:96" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.51.e.1" text="urea" type="Biomedical_Entity"><Normalization><mmtx cui="C0041942" phraseText="in blood urea nitrogen." preferredWord="Urea" semType="bacs, phsu, orch"/><RxNorm RxCui="11002"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.51.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.51.e.1"/></sentence><sentence biomedicalEntities="4" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52" lineNumber="36" text="Caution should be exercised when INNOPRAN XL is administered with drugs that have an effect on CYP2D6, 1A2, or 2C19 metabolic pathways. " type="regular"><entity charOffset="0:7" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.0" text="Caution" type="Caution_Interaction"/><entity charOffset="33:44" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.2" text="INNOPRAN XL" type="Drug"><Normalization><mmtx cui="C1311856" phraseText="INNOPRAN XL" preferredWord="Innopran XL" semType="phsu, orch"/><RxNorm RxCui="856468"/></Normalization></entity><entity charOffset="66:101|116:134" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.3" text="drugs that have an effect on CYP2D6 metabolic pathways" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="administered with drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="66:94|103:106|116:134" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.4" text="drugs that have an effect on 1A2 metabolic pathways" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="administered with drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="66:94|111:134" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.5" text="drugs that have an effect on 2C19 metabolic pathways" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="administered with drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.4" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.0" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.3" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.0" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.5" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.0" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.3" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.4"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.5" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.4"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.5" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.3"/></sentence><sentence biomedicalEntities="1" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53" lineNumber="36" text="Co-administration of such drugs with propranolol may lead to clinically relevant drug interactions and changes on its efficacy and/or toxicity (see CLINICAL PHARMACOLOGY, Drug Interactions)." type="regular"><anaphoraRelation><antecedentSentence ID="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52" Text="Caution should be exercised when INNOPRAN XL is administered with drugs that have an effect on CYP2D6, 1A2, or 2C19 metabolic pathways. "/><anaphoraEntity charOffset="21:31" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.1" text="such drugs" type="Expression"/><antecedentEntity charOffset="66:134" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.3" text="drugs that have an effect on CYP2D6 metabolic pathways" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52" Text="Caution should be exercised when INNOPRAN XL is administered with drugs that have an effect on CYP2D6, 1A2, or 2C19 metabolic pathways. "/><anaphoraEntity charOffset="21:31" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.1" text="such drugs" type="Expression"/><antecedentEntity charOffset="66:134" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.4" text="drugs that have an effect on 1A2 metabolic pathways" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52" Text="Caution should be exercised when INNOPRAN XL is administered with drugs that have an effect on CYP2D6, 1A2, or 2C19 metabolic pathways. "/><anaphoraEntity charOffset="21:31" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.1" text="such drugs" type="Expression"/><antecedentEntity charOffset="66:134" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.5" text="drugs that have an effect on 2C19 metabolic pathways" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52" Text="Caution should be exercised when INNOPRAN XL is administered with drugs that have an effect on CYP2D6, 1A2, or 2C19 metabolic pathways. "/><anaphoraEntity charOffset="21:31" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.1" text="such drugs" type="Expression"/><antecedentEntity charOffset="66:134" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.3" text="drugs that have an effect on CYP2D6 metabolic pathways" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52" Text="Caution should be exercised when INNOPRAN XL is administered with drugs that have an effect on CYP2D6, 1A2, or 2C19 metabolic pathways. "/><anaphoraEntity charOffset="21:31" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.1" text="such drugs" type="Expression"/><antecedentEntity charOffset="66:134" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.4" text="drugs that have an effect on 1A2 metabolic pathways" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52" Text="Caution should be exercised when INNOPRAN XL is administered with drugs that have an effect on CYP2D6, 1A2, or 2C19 metabolic pathways. "/><anaphoraEntity charOffset="21:31" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.1" text="such drugs" type="Expression"/><antecedentEntity charOffset="66:134" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.5" text="drugs that have an effect on 2C19 metabolic pathways" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52" Text="Caution should be exercised when INNOPRAN XL is administered with drugs that have an effect on CYP2D6, 1A2, or 2C19 metabolic pathways. "/><anaphoraEntity charOffset="21:31" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.1" text="such drugs" type="Expression"/><antecedentEntity charOffset="66:134" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.3" text="drugs that have an effect on CYP2D6 metabolic pathways" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52" Text="Caution should be exercised when INNOPRAN XL is administered with drugs that have an effect on CYP2D6, 1A2, or 2C19 metabolic pathways. "/><anaphoraEntity charOffset="21:31" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.1" text="such drugs" type="Expression"/><antecedentEntity charOffset="66:134" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.4" text="drugs that have an effect on 1A2 metabolic pathways" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52" Text="Caution should be exercised when INNOPRAN XL is administered with drugs that have an effect on CYP2D6, 1A2, or 2C19 metabolic pathways. "/><anaphoraEntity charOffset="21:31" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.1" text="such drugs" type="Expression"/><antecedentEntity charOffset="66:134" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.52.e.5" text="drugs that have an effect on 2C19 metabolic pathways" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="114:117" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.7" text="its" type="Expression"/><antecedentEntity charOffset="37-48" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.0" text="propranolol" type="Drug"/></anaphoraRelation><entity charOffset="37:48" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.0" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="with propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="103:113|118:126" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.5" text="changes on efficacy" type="Specific_Interaction"/><entity charOffset="103:113|134:142" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.9" text="changes on toxicity" type="Increase_Interaction"/><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.5"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.ddi.2"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.9"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.7" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.53.e.5" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54" lineNumber="37" text="Plasma propranolol levels may increase with acute alcohol consumption and decrease upon chronic alcohol use." type="regular"><entity charOffset="0:6|19:25|30:38" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54.e.0" text="Plasma levels increase" type="Increase_Interaction"/><entity charOffset="50:57" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54.e.2" text="alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="increase with acute alcohol consumption" preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="7:18" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54.e.3" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="Plasma propranolol levels" preferredWord="Propranolol" semType="phsu, orch"/><mmtx cui="C0033497" phraseText="Plasma propranolol levels" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="0:6|19:25|74:82" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54.e.4" text="Plasma levels decrease" type="Decrease_Interaction"/><entity charOffset="96:103" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54.e.6" text="alcohol" type="Substance"><Normalization><mmtx cui="C0001975" phraseText="decrease upon chronic alcohol use." preferredWord="Alcohols" semType="phsu, orch"/><RxNorm RxCui="448"/></Normalization></entity><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54.e.0"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54.ddi.2"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54.e.4"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54.e.3" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54.e.2" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54.e.0" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54.e.3" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54.e.6" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.54.e.4" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.55" lineNumber="38" text="When combined with beta-blockers, ACE inhibitors can cause hypotension, particularly in the setting of acute myocardial infraction." type="regular"><entity charOffset="19:32" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.55.e.0" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="combined with beta-blockers," preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="34:48" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.55.e.1" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="59:70" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.55.e.2" text="hypotension" type="Specific_Interaction"/><entity charOffset="103:130" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.55.e.4" text="acute myocardial infraction" type="SPAN"/><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.55.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.55.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.55.e.1"/></relation><relation type="hasContext"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.55.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.55.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.55.e.4" ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.55.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.55.e.1" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.55.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.56" lineNumber="39" text="The antihypertensive effects of clonidine may be antagonized by beta-blockers. " type="regular"><entity charOffset="4:28|49:60" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.56.e.0" text="antihypertensive effects antagonized" type="Specific_Interaction"/><entity charOffset="32:41" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.56.e.2" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="The antihypertensive effects of clonidine" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="64:77" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.56.e.3" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="antagonized by beta-blockers." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.56.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.56.e.0"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.56.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.56.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.56.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.56.e.3" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.56.e.0" type="Specific_Interaction"/></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.57" text="INNOPRAN XL should be administered cautiously to patients withdrawing from clonidine." type="negative"><entity charOffset="75:84" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.57.e.0" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="withdrawing from clonidine." preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="0:11" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.57.e.1" text="innopran xl" type="Biomedical_Entity"><Normalization><mmtx cui="C1311856" phraseText="INNOPRAN XL" preferredWord="Innopran XL" semType="phsu, orch"/><RxNorm RxCui="856468"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.57.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.57.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.58" lineNumber="40" text="Prazosin has been associated with prolongation of first dose hypotension in the presence of beta-blockers." type="regular"><entity charOffset="34:72" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.58.e.0" text="prolongation of first dose hypotension" type="Specific_Interaction"/><entity charOffset="0:8" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.58.e.2" text="Prazosin" type="Drug"><Normalization><mmtx cui="C0032912" phraseText="Prazosin" preferredWord="Prazosin" semType="phsu, orch"/><RxNorm RxCui="8629"/></Normalization></entity><entity charOffset="92:105" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.58.e.3" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="of beta-blockers." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.58.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.58.e.0"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.58.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.58.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.58.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.58.e.3" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.58.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.59" lineNumber="41" text="Postural hypotension has been reported in patients taking both beta-blockers and terazosin or doxazosin." type="regular"><entity charOffset="0:20" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.59.e.0" text="Postural hypotension" type="Specific_Interaction"/><entity charOffset="63:76" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.59.e.2" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="both beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="81:90" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.59.e.3" text="terazosin" type="Drug"><Normalization><mmtx cui="C0076107" phraseText="terazosin" preferredWord="Terazosin" semType="phsu, orch"/><RxNorm RxCui="37798"/></Normalization></entity><entity charOffset="94:103" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.59.e.4" text="doxazosin" type="Drug"><Normalization><mmtx cui="C0114873" phraseText="doxazosin." preferredWord="Doxazosin" semType="phsu, orch"/><RxNorm RxCui="39173"/></Normalization></entity><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.59.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.59.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.59.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.59.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.59.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.59.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.59.e.3" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.59.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.59.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.59.e.4" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.59.e.0" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.59.e.3" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.59.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.60" lineNumber="42" text="Propafenone has negative inotropic and beta-blocking properties that can be additive to those of propranolol." type="regular"><entity charOffset="0:11" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.60.e.0" text="Propafenone" type="Drug"><Normalization><mmtx cui="C0033429" phraseText="Propafenone" preferredWord="Propafenone" semType="phsu, orch"/><RxNorm RxCui="8754"/></Normalization></entity><entity charOffset="97:108" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.60.e.1" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="additive to those of propranolol." preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="16:34|53:84" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.60.e.2" text="negative inotropic properties that can be additive" type="Specific_Interaction"/><entity charOffset="16:24|39:84" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.60.e.4" text="negative beta-blocking properties that can be additive" type="Specific_Interaction"/><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.60.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.60.e.2"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.60.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.60.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.60.ddi.2"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.60.e.4"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.60.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.60.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.60.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.60.e.1" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.60.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61" lineNumber="43" text="Quinidine increases the concentration of propranolol and produces greater degrees of clinical beta-blockade and may cause postural hypotension." type="regular"><entity charOffset="0:9" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.e.0" text="Quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="Quinidine" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="10:37" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.e.1" text="increases the concentration" type="Increase_Interaction"/><entity charOffset="41:52" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.e.3" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="the concentration of propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="57:107" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.e.4" text="produces greater degrees of clinical beta-blockade" type="Increase_Interaction"/><entity charOffset="122:142" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.e.6" text="postural hypotension" type="Specific_Interaction"/><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.e.1"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.ddi.2"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.e.4"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.ddi.3"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.e.6"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.e.3" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.61.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.62" lineNumber="44" text="Amiodarone is an antiarrhythmic agent with negative chronotropic properties that may be additive to those seen with -blockers such as propranolol." type="regular"><entity charOffset="0:10" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.62.e.0" text="Amiodarone" type="Drug"><Normalization><mmtx cui="C0002598" phraseText="Amiodarone" preferredWord="Amiodarone" semType="phsu, orch"/><RxNorm RxCui="203114"/></Normalization></entity><entity charOffset="17:37" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.62.e.1" text="antiarrhythmic agent" type="Drug_Class"><Normalization><mmtx cui="C0003195" phraseText="an antiarrhythmic agent with negative chronotropic properties" preferredWord="Anti-Arrhythmia Agents" semType="phsu"/><RxNorm RxCui="883"/></Normalization></entity><entity charOffset="134:145" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.62.e.3" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="such as propranolol." preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="43:96" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.62.e.4" text="negative chronotropic properties that may be additive" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.62.e.0" drugClass="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.62.e.1"/><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.62.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.62.e.4"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.62.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.62.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.62.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.62.e.3" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.62.e.4" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.63" lineNumber="45" text="The clearance of lidocaine and bupivacaine are significantly reduced with administration of propranolol. " type="regular"><entity charOffset="17:26" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.63.e.0" text="lidocaine" type="Drug"><Normalization><mmtx cui="C0023660" phraseText="The clearance of lidocaine" preferredWord="Lidocaine" semType="phsu, orch"/><RxNorm RxCui="6387"/></Normalization></entity><entity charOffset="31:42" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.63.e.1" text="bupivacaine" type="Drug"><Normalization><mmtx cui="C0006400" phraseText="bupivacaine" preferredWord="Bupivacaine" semType="phsu, orch"/><RxNorm RxCui="267396"/></Normalization></entity><entity charOffset="4:13|61:68" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.63.e.2" text="clearance reduced" type="Increase_Interaction"/><entity charOffset="92:103" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.63.e.4" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="reduced with administration of propranolol." preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.63.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.63.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.63.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.63.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.63.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.63.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.63.e.4" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.63.e.2" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.63.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.63.e.4" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.63.e.2" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.64" lineNumber="45" text="Lidocaine and bupivacaine toxicity has been reported following coadministration with propranolol. " type="regular"><entity charOffset="26:34" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.64.e.0" text="toxicity" type="Increase_Interaction"/><entity charOffset="0:9" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.64.e.2" text="Lidocaine" type="Drug"><Normalization><mmtx cui="C0023660" phraseText="Lidocaine" preferredWord="Lidocaine" semType="phsu, orch"/><RxNorm RxCui="6387"/></Normalization></entity><entity charOffset="14:25" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.64.e.3" text="bupivacaine" type="Drug"><Normalization><mmtx cui="C0006400" phraseText="bupivacaine toxicity" preferredWord="Bupivacaine" semType="phsu, orch"/><RxNorm RxCui="267396"/></Normalization></entity><entity charOffset="85:96" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.64.e.4" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="coadministration with propranolol." preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.64.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.64.e.0"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.64.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.64.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.64.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.64.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.64.e.4" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.64.e.0" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.64.e.3" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.64.e.4" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.64.e.0" type="Increase_Interaction"/></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.65" text="(see also PRECAUTIONS, Drug Interactions, Non-Cardiovascular Drugs, Anesthetic Agents)" type="negative"><entity charOffset="68:85" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.65.e.0" text="anesthetic agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0002932" phraseText="Anesthetic Agents" preferredWord="Anesthetics" semType="phsu"/><RxNorm RxCui="817"/></Normalization></entity><entity charOffset="46:66" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.65.e.1" text="cardiovascular drugs" type="Biomedical_Entity"><Normalization><mmtx cui="C0007220" phraseText="Non-Cardiovascular Drugs," preferredWord="Cardiovascular Agents" semType="phsu"/><RxNorm RxCui="1021827"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.65.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.65.e.0"/></sentence><sentence biomedicalEntities="5" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.66" lineNumber="46" text="Caution should be exercised when administering INNOPRAN XL with drugs that slow A-V nodal conduction, e.g. digitalis, lidocaine, and calcium channel blockers." type="regular"><entity charOffset="0:7" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.66.e.0" text="Caution" type="Caution_Interaction"/><entity charOffset="47:58" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.66.e.2" text="INNOPRAN XL" type="Drug"><Normalization><mmtx cui="C1311856" phraseText="administering INNOPRAN XL with drugs" preferredWord="Innopran XL" semType="phsu, orch"/><RxNorm RxCui="856468"/></Normalization></entity><entity charOffset="64:100" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.66.e.3" text="drugs that slow A-V nodal conduction" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="administering INNOPRAN XL with drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="107:116" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.66.e.4" text="digitalis" type="Drug"><Normalization><mmtx cui="C0304520" phraseText="e.g. digitalis," preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="118:127" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.66.e.5" text="lidocaine" type="Drug"><Normalization><mmtx cui="C0023660" phraseText="lidocaine," preferredWord="Lidocaine" semType="phsu, orch"/><RxNorm RxCui="6387"/></Normalization></entity><entity charOffset="133:157" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.66.e.6" text="calcium channel blockers" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="calcium channel blockers." preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><drugClassMembership drug="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.66.e.4" drugClass="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.66.e.3"/><drugClassMembership drug="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.66.e.5" drugClass="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.66.e.3"/><classClassMembership drugClass="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.66.e.6"/><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.66.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.66.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.66.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.66.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.66.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.66.e.3" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.66.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.67" lineNumber="47" text="Caution should be exercised when patients receiving a beta-blocker are administered a calcium-channel-blocking drug with negative inotropic and/or chronotropic effects. " type="regular"><entity charOffset="54:66" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.67.e.0" text="beta-blocker" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="a beta-blocker" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="86:167" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.67.e.1" text="calcium-channel-blocking drug with negative inotropic and/or chronotropic effects" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="a calcium-channel-blocking drug with negative inotropic" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1899"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.67.e.2" text="Caution" type="Caution_Interaction"/><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.67.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.67.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.67.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.67.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.67.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.67.e.1" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.67.e.2" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.68" lineNumber="47" text="Both agents may depress myocardial contractility or atrioventricular conduction." type="irregular"><entity charOffset="16:48" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.68.e.0" text="depress myocardial contractility" type="Specific_Interaction"/><entity charOffset="16:23|52:79" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.68.e.2" text="depress atrioventricular conduction" type="Specific_Interaction"/><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.68.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.68.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.67" text="Caution should be exercised when patients receiving a beta-blocker are administered a calcium-channel-blocking drug with negative inotropic and/or chronotropic effects. "><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.67.e.1"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.67" text="Caution should be exercised when patients receiving a beta-blocker are administered a calcium-channel-blocking drug with negative inotropic and/or chronotropic effects. "><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.67.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.68.ddi.2"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.68.e.2"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.67" text="Caution should be exercised when patients receiving a beta-blocker are administered a calcium-channel-blocking drug with negative inotropic and/or chronotropic effects. "><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.67.e.1"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.67" text="Caution should be exercised when patients receiving a beta-blocker are administered a calcium-channel-blocking drug with negative inotropic and/or chronotropic effects. "><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.67.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69" lineNumber="48" text="There have been reports of significant bradycardia, heart failure, and cardiovascular collapse with concurrent use of verapamil and beta-blockers." type="regular"><entity charOffset="39:50" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.e.0" text="bradycardia" type="Specific_Interaction"/><entity charOffset="52:65" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.e.2" text="heart failure" type="Specific_Interaction"><Normalization><mmtx cui="C0018801" phraseText="heart failure," preferredWord="Heart failure" semType="dsyn"/><mmtx cui="C0018802" phraseText="heart failure," preferredWord="Congestive heart failure" semType="dsyn"/></Normalization></entity><entity charOffset="71:94" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.e.4" text="cardiovascular collapse" type="Specific_Interaction"/><entity charOffset="118:127" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.e.6" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="cardiovascular collapse with concurrent use of verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="132:145" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.e.7" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.e.0"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.e.6"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.ddi.2"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.e.2"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.e.6"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.ddi.3"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.e.4"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.e.6" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.e.7" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.69.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70" lineNumber="49" text="Co-administration of propranolol and diltiazem in patients with cardiac disease has been associated with bradycardia, hypotension, high degree heart block, and heart failure." type="regular"><entity charOffset="21:32" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.0" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="Co-administration of propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="64:79" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.1" text="cardiac disease" type="SPAN"><Normalization><mmtx cui="C0018799" phraseText="with cardiac disease" preferredWord="Heart Diseases" semType="dsyn"/></Normalization></entity><entity charOffset="37:46" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.2" text="diltiazem" type="Drug"><Normalization><mmtx cui="C0012373" phraseText="diltiazem in patients" preferredWord="Diltiazem" semType="phsu, orch"/><RxNorm RxCui="203211"/></Normalization></entity><entity charOffset="105:116" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.3" text="bradycardia" type="Specific_Interaction"/><entity charOffset="118:129" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.5" text="hypotension" type="Specific_Interaction"/><entity charOffset="143:154" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.7" text="heart block" type="Specific_Interaction"/><entity charOffset="160:173" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.9" text="heart failure" type="Specific_Interaction"><Normalization><mmtx cui="C0018801" phraseText="heart failure." preferredWord="Heart failure" semType="dsyn"/><mmtx cui="C0018802" phraseText="heart failure." preferredWord="Congestive heart failure" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.3"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.ddi.2"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.5"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.ddi.3"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.7"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.ddi.4"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.9"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.1"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.1" ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.2" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.70.e.3" type="Specific_Interaction"/></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.71" text="Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. " type="negative"><entity charOffset="30:43" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.71.e.0" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers slow atrioventricular conduction" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="5:25" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.71.e.1" text="digitalis glycosides" type="Biomedical_Entity"><Normalization><mmtx cui="C0012253" phraseText="Both digitalis glycosides" preferredWord="Digitalis Glycosides" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.71.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.71.e.0"/></sentence><sentence biomedicalEntities="0" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.72" lineNumber="50" text="Concomitant use can increase the risk of bradycardia." type="irregular"><entity charOffset="41:52" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.72.e.0" text="bradycardia" type="Specific_Interaction"/><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.72.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.72.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.71" text="Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. "><entity charOffset="5:25" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.71.e.0" text="digitalis glycosides" type="Drug_Class"><Normalization><mmtx cui="C0012253" phraseText="Both digitalis glycosides" preferredWord="Digitalis Glycosides" semType="phsu, carb"/></Normalization></entity></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.71" text="Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. "><entity charOffset="30:43" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.71.e.1" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers slow atrioventricular conduction" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.73" lineNumber="51" text="Patients on long-term therapy with propranolol may experience uncontrolled hypertension if administered epinephrine as a consequence of unopposed alpha-receptor stimulation. " type="regular"><entity charOffset="35:46" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.73.e.0" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="with propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="104:115" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.73.e.1" text="epinephrine" type="Drug"><Normalization><mmtx cui="C0014563" phraseText="administered epinephrine as a consequence of unopposed alpha-receptor stimulation." preferredWord="Epinephrine" semType="phsu, orch, horm, nsba"/><RxNorm RxCui="362"/></Normalization></entity><entity charOffset="62:87" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.73.e.2" text="uncontrolled hypertension" type="Specific_Interaction"><Normalization><mmtx cui="C0020538" phraseText="uncontrolled hypertension" preferredWord="Hypertensive disease" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.73.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.73.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.73.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.73.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.73.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.73.e.1" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.73.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.74" lineNumber="51" text="Epinephrine is therefore not indicated in the treatment of propranolol overdose (see OVERDOSAGE)." type="regular"><entity charOffset="25:38" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.74.e.0" text="not indicated" type="Caution_Interaction"/><entity charOffset="0:11" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.74.e.2" text="Epinephrine" type="Drug"><Normalization><mmtx cui="C0014563" phraseText="Epinephrine" preferredWord="Epinephrine" semType="phsu, orch, horm, nsba"/><RxNorm RxCui="362"/></Normalization></entity><entity charOffset="59:70" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.74.e.3" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="indicated in the treatment of propranolol overdose" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.74.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.74.e.0"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.74.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.74.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.74.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.74.e.3" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.74.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75" lineNumber="52" text="Propranolol is a competitive inhibitor of beta-receptor agonists, and its effects can be reversed by administration of such agents, e.g., dobutamine or isoproterenol. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="119:130" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.e.0" text="such agents" type="Expression"/><antecedentEntity charOffset="42-64" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.e.1" text="beta-receptor agonists" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="70:73" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.e.7" text="its" type="Expression"/><antecedentEntity charOffset="0-11" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.e.8" text="Propranolol" type="Drug"/></anaphoraRelation><entity charOffset="42:64" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.e.1" text="beta-receptor agonists" type="Drug_Class"><Normalization><mmtx cui="C0243192" phraseText="a competitive inhibitor of beta-receptor agonists," preferredWord="agonists" semType="phsu"/><mmtx cui="C2987634" phraseText="a competitive inhibitor of beta-receptor agonists," preferredWord="Agonist" semType="phsu"/><RxNorm RxCui="38483"/></Normalization></entity><entity charOffset="138:148" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.e.3" text="dobutamine" type="Drug"><Normalization><mmtx cui="C0012963" phraseText="dobutamine" preferredWord="Dobutamine" semType="phsu, orch"/><RxNorm RxCui="203121"/></Normalization></entity><entity charOffset="152:165" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.e.4" text="isoproterenol" type="Drug"><Normalization><mmtx cui="C0022245" phraseText="isoproterenol." preferredWord="Isoproterenol" semType="phsu, orch"/><RxNorm RxCui="82030"/></Normalization></entity><entity charOffset="0:11" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.e.8" text="Propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="Propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="74:81|89:97" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.e.10" text="effects reversed" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.e.3" drugClass="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.e.0"/><drugClassMembership drug="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.e.4" drugClass="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.e.0"/><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.e.10"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.e.8"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.e.8" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.e.0" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.75.e.10" type="Specific_Interaction"/></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.76" text="Also, propranolol may reduce sensitivity to dobutamine stress echocardiography in patients undergoing evaluation for myocardial ischemia." type="negative"><entity charOffset="6:17" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.76.e.0" text="propranolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033497" phraseText="propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="44:54" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.76.e.1" text="dobutamine" type="Biomedical_Entity"><Normalization><mmtx cui="C0012963" phraseText="sensitivity to dobutamine stress echocardiography" preferredWord="Dobutamine" semType="phsu, orch"/><RxNorm RxCui="203121"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.76.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.76.e.1"/></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.77" text="Patients receiving catecholamine-depleting drugs, such as reserpine and INNOPRAN XL, should be closely observed for excessive reduction of resting sympathetic nervous activity, which may result in hypotension, marked bradycardia, vertigo, syncopal attacks, or orthostatic hypotension." type="negative"><entity charOffset="58:67" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.77.e.0" text="reserpine" type="Biomedical_Entity"><Normalization><mmtx cui="C0035179" phraseText="such as reserpine" preferredWord="Reserpine" semType="phsu, orch"/><RxNorm RxCui="9260"/></Normalization></entity><entity charOffset="19:32" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.77.e.1" text="catecholamine" type="Biomedical_Entity"><Normalization><mmtx cui="C0007412" phraseText="catecholamine-depleting drugs," preferredWord="Catecholamines" semType="phsu, nsba"/><RxNorm RxCui="2146"/></Normalization></entity><entity charOffset="72:83" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.77.e.2" text="innopran xl" type="Biomedical_Entity"><Normalization><mmtx cui="C1311856" phraseText="INNOPRAN XL," preferredWord="Innopran XL" semType="phsu, orch"/><RxNorm RxCui="856468"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.77.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.77.e.0"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.77.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.77.e.2"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.77.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.77.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.78" lineNumber="54" text="Methoxyflurane and trichloroethylene may depress myocardial contractility when administered with propranolol." type="regular"><entity charOffset="0:14" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.78.e.0" text="Methoxyflurane" type="Drug"><Normalization><mmtx cui="C0025688" phraseText="Methoxyflurane" preferredWord="Methoxyflurane" semType="phsu, orch"/><RxNorm RxCui="6857"/></Normalization></entity><entity charOffset="19:36" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.78.e.1" text="trichloroethylene" type="Drug"><Normalization><mmtx cui="C0040905" phraseText="trichloroethylene" preferredWord="Trichloroethylene" semType="phsu, orch"/><RxNorm RxCui="10777"/></Normalization></entity><entity charOffset="41:73" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.78.e.2" text="depress myocardial contractility" type="Specific_Interaction"/><entity charOffset="97:108" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.78.e.4" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="administered with propranolol." preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.78.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.78.e.2"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.78.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.78.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.78.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.78.e.1" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.78.e.4" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.78.e.2" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.78.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.78.e.4" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.78.e.2" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.78.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.78.e.1"/></sentence><sentence biomedicalEntities="5" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79" lineNumber="55" text="The clearance of local amide anesthetics (e.g., lidocaine, bupivacaine, mepivacaine) is reduced with administration of propranolol. " type="regular"><entity charOffset="88:95|4:13" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79.e.0" text="reduced clearance" type="Increase_Interaction"/><entity charOffset="17:40" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79.e.2" text="local amide anesthetics" type="Drug_Class"><Normalization><mmtx cui="C3539945" phraseText="The clearance of local amide anesthetics" preferredWord="Amide local anesthetics" semType="phsu, orch"/><RxNorm RxCui="992023"/></Normalization></entity><entity charOffset="48:57" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79.e.3" text="lidocaine" type="Drug"><Normalization><mmtx cui="C0023660" phraseText="lidocaine," preferredWord="Lidocaine" semType="phsu, orch"/><RxNorm RxCui="6387"/></Normalization></entity><entity charOffset="59:70" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79.e.4" text="bupivacaine" type="Drug"><Normalization><mmtx cui="C0006400" phraseText="bupivacaine," preferredWord="Bupivacaine" semType="phsu, orch"/><RxNorm RxCui="267396"/></Normalization></entity><entity charOffset="72:83" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79.e.5" text="mepivacaine" type="Drug"><Normalization><mmtx cui="C0025384" phraseText="mepivacaine" preferredWord="Mepivacaine" semType="phsu, orch"/><RxNorm RxCui="6759"/></Normalization></entity><entity charOffset="119:130" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79.e.9" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="reduced with administration of propranolol." preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><drugClassMembership drug="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79.e.3" drugClass="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79.e.2"/><drugClassMembership drug="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79.e.4" drugClass="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79.e.2"/><drugClassMembership drug="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79.e.5" drugClass="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79.e.2"/><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79.e.9"/></relation><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79.e.9" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.79.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.80" lineNumber="55" text="Lidocaine and bupivacaine toxicity has been reported following coadministration with propranolol. " type="regular"><entity charOffset="26:34" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.80.e.0" text="toxicity" type="Increase_Interaction"/><entity charOffset="0:9" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.80.e.2" text="Lidocaine" type="Drug"><Normalization><mmtx cui="C0023660" phraseText="Lidocaine" preferredWord="Lidocaine" semType="phsu, orch"/><RxNorm RxCui="6387"/></Normalization></entity><entity charOffset="14:25" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.80.e.3" text="bupivacaine" type="Drug"><Normalization><mmtx cui="C0006400" phraseText="bupivacaine toxicity" preferredWord="Bupivacaine" semType="phsu, orch"/><RxNorm RxCui="267396"/></Normalization></entity><entity charOffset="85:96" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.80.e.4" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="coadministration with propranolol." preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.80.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.80.e.0"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.80.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.80.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.80.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.80.e.3" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.80.e.4" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.80.e.0" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.80.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.80.e.4" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.80.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.81" lineNumber="55" text="Caution should be exercised when amide anesthetic agents are administered concomitantly with propanolol." type="regular"><entity charOffset="0:7" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.81.e.0" text="Caution" type="Caution_Interaction"/><entity charOffset="33:56" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.81.e.2" text="amide anesthetic agents" type="Drug_Class"><Normalization><mmtx cui="C0002932" phraseText="amide anesthetic agents" preferredWord="Anesthetics" semType="phsu"/><RxNorm RxCui="1430373"/></Normalization></entity><entity charOffset="93:103" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.81.e.3" text="propanolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="concomitantly with propanolol." preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="8787"/></Normalization></entity><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.81.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.81.e.0"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.81.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.81.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.81.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.81.e.3" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.81.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82" lineNumber="56" text="The hypotensive effects of MAO inhibitors or tricyclic antidepressants may be exacerbated when administered with beta-blockers by interfering with the beta-blocking activity of propranolol." type="regular"><entity charOffset="4:23|78:89" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.e.0" text="hypotensive effects exacerbated" type="Specific_Interaction"/><entity charOffset="27:41" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.e.2" text="MAO inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0026457" phraseText="The hypotensive effects of MAO inhibitors" preferredWord="Monoamine Oxidase Inhibitors" semType="phsu, orch"/><RxNorm RxCui="7029"/></Normalization></entity><entity charOffset="45:70" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.e.3" text="tricyclic antidepressants" type="Drug_Class"><Normalization><mmtx cui="C0003290" phraseText="tricyclic antidepressants" preferredWord="Tricyclic Antidepressive Agents" semType="phsu"/><RxNorm RxCui="928"/></Normalization></entity><entity charOffset="113:126" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.e.4" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="administered with beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="177:188" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.e.5" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="interfering with the beta-blocking activity of propranolol." preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><drugClassMembership drug="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.e.5" drugClass="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.e.4"/><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.e.0"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.e.3" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.e.4" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.e.4" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.e.0" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.82.e.3"/></sentence><sentence biomedicalEntities="2" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.83" lineNumber="57" text="Hypotension and cardiac arrest have been reported with the concomitant use of propranolol and haloperidol." type="regular"><entity charOffset="0:11" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.83.e.0" text="Hypotension" type="Specific_Interaction"/><entity charOffset="16:30" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.83.e.2" text="cardiac arrest" type="Specific_Interaction"><Normalization><mmtx cui="C0018790" phraseText="cardiac arrest" preferredWord="Cardiac Arrest" semType="dsyn"/></Normalization></entity><entity charOffset="78:89" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.83.e.4" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="reported with the concomitant use of propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="94:105" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.83.e.5" text="haloperidol" type="Drug"><Normalization><mmtx cui="C0018546" phraseText="haloperidol." preferredWord="Haloperidol" semType="phsu, orch"/><RxNorm RxCui="26420"/></Normalization></entity><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.83.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.83.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.83.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.83.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.83.ddi.2"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.83.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.83.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.83.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.83.e.4" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.83.e.5" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.83.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.84" lineNumber="58" text="Nonsteroidal anti-inflammatory drugs (NSAIDS) have been reported to blunt the antihypertensive effect of beta-adrenoreceptor blocking agents." type="regular"><entity charOffset="68:101" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.84.e.0" text="blunt the antihypertensive effect" type="Specific_Interaction"/><entity charOffset="0:45" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.84.e.2" text="Nonsteroidal anti-inflammatory drugs (NSAIDS)" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="Nonsteroidal anti-inflammatory drugs (NSAIDS)" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="402125"/></Normalization></entity><entity charOffset="105:140" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.84.e.3" text="beta-adrenoreceptor blocking agents" type="Drug_Class"><Normalization><mmtx cui="C0003364" phraseText="the antihypertensive effect of beta-adrenoreceptor blocking agents." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="1459789"/></Normalization></entity><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.84.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.84.e.0"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.84.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.84.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.84.e.2" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.84.e.3" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.84.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.85" lineNumber="59" text="Administration of indomethacin with propranolol may reduce the efficacy of propranolol in reducing blood pressure and heart rate." type="regular"><entity charOffset="18:30" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.85.e.0" text="indomethacin" type="Drug"><Normalization><mmtx cui="C0021246" phraseText="Administration of indomethacin" preferredWord="Indomethacin" semType="phsu, orch"/><RxNorm RxCui="5781"/></Normalization></entity><entity charOffset="75:86" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.85.e.1" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="the efficacy of propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="52:71" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.85.e.2" text="reduce the efficacy" type="Decrease_Interaction"/><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.85.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.85.e.2"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.85.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.85.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.85.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.85.e.1" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.85.e.2" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.86" lineNumber="60" text="Thyroxine may result in a lower than expected T3 concentration when used concomitantly with propranolol." type="regular"><entity charOffset="0:9" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.86.e.0" text="Thyroxine" type="Drug"><Normalization><mmtx cui="C0040165" phraseText="Thyroxine" preferredWord="Thyroxine" semType="phsu, aapp, horm"/><RxNorm RxCui="10582"/></Normalization></entity><entity charOffset="92:103" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.86.e.1" text="propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="concomitantly with propranolol." preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="26:62" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.86.e.2" text="lower than expected T3 concentration" type="Specific_Interaction"/><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.86.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.86.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.86.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.86.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.86.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.86.e.1" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.86.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.87" lineNumber="61" text="Propranolol when administered with warfarin increases the concentration of warfarin. " type="regular"><entity charOffset="0:11" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.87.e.0" text="Propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="Propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="44:71" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.87.e.1" text="increases the concentration" type="Increase_Interaction"/><entity charOffset="75:83" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.87.e.3" text="warfarin" type="Drug"><Normalization><mmtx cui="C0043031" phraseText="the concentration of warfarin." preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.87.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.87.e.1"><relations><relation type="hasObject"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.87.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.87.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.87.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.87.e.3" trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.87.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.88" lineNumber="61" text="Prothrombin time, therefore, should be monitored." type="irregular"><entity charOffset="39:48" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.88.e.0" text="monitored" type="Caution_Interaction"/><drugInteraction id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.88.ddi.1"><interaction trigger="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.88.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.87" text="Propranolol when administered with warfarin increases the concentration of warfarin. "><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.87.e.0"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.87" text="Propranolol when administered with warfarin increases the concentration of warfarin. "><entity id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.87.e.3"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.90" text="On a body surface area basis, this dose in the mouse and rat is, respectively, about equal to and about twice the maximum recommended human oral daily dose (MRHD) of 640 mg propranolol HCl. " type="negative"><entity charOffset="23:28" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.90.e.0" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="On a body surface area basis," preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="173:188" id="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.90.e.1" text="propranolol hcl" type="Biomedical_Entity"><Normalization><mmtx cui="C0282321" phraseText="of 640 mg propranolol HCl." preferredWord="Propranolol Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><pair ddi="false" e1="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.90.e.0" e2="Dailymed.45806bf7-893a-4dd6-b9ab-c4dc6ce53946.s.90.e.1"/></sentence><positiveExamples number="40"/><negativeExamples number="81"/></document>